StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.51+0.21 (+6.36%)

Close on Nov 17, 2026Market cap $30.65MP/E –Yield –

BriaCell Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BriaCell Therapeutics's market cap was $31.26M on Nov 11, 2026, against $5.10M a year earlier. Over the last 5 years it ranged from $4.89M to $151.09M, with a median of $31.63M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$31.26M+70.5%
2025Nov 28, 2025$18.33M-10.3%
2024Dec 31, 2024$20.44M-78.1%
2023Dec 29, 2023$93.49M+37.1%
2022Dec 30, 2022$68.19M-46.4%
2021Dec 31, 2021$127.14M+4147.3%
2020Dec 31, 2020$2.99M–

More BriaCell Therapeutics figures

See a number that looks wrong?